Yorktown Management & Research Company’s Hinge Health HNGE Stock Holding History

Yorktown Management & Research Company’s Portfolio HNGE Stock Details HNGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$556K	Buy	+6,700	New	+$364K	0.34%	109

Other funds holding HNGE

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Yorktown Management & Research Company's HNGE Position: Q2 2026 in Review

Yorktown Management & Research Company opened a new position in Hinge Health (HNGE) in Q2 2026: 6,700 shares worth $556K. The stake represents 0.34% of the portfolio and ranks #109 among its holdings.

57 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

Yorktown Management & Research Company held 6,700 shares of Hinge Health worth $556K as of Q2 2026.
Hinge Health was a new Yorktown Management & Research Company position in Q2 2026.
Hinge Health made up 0.34% of Yorktown Management & Research Company's portfolio in Q2 2026, its #109 holding.
57 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Yorktown Management & Research Company's 13F filing for Q2 2026, filed 23 Jul 2026.